Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5266272
Max Phase: Preclinical
Molecular Formula: C59H77N9O11S3
Molecular Weight: 1184.52
Associated Items:
ID: ALA5266272
Max Phase: Preclinical
Molecular Formula: C59H77N9O11S3
Molecular Weight: 1184.52
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(C(C)NC(=O)C2CC(O)CN2C(=O)C(NC(=O)COCCOCCOCCOCCNC(=O)c2ccc(CN3CCN(S(=O)(=O)c4ccc(NC(=S)NCc5ccccc5)cc4)CC3)cc2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C59H77N9O11S3/c1-41(45-15-17-46(18-16-45)53-42(2)62-40-81-53)63-56(72)51-35-49(69)38-68(51)57(73)54(59(3,4)5)65-52(70)39-79-34-33-78-32-31-77-30-29-76-28-23-60-55(71)47-13-11-44(12-14-47)37-66-24-26-67(27-25-66)82(74,75)50-21-19-48(20-22-50)64-58(80)61-36-43-9-7-6-8-10-43/h6-22,40-41,49,51,54,69H,23-39H2,1-5H3,(H,60,71)(H,63,72)(H,65,70)(H2,61,64,80)
Standard InChI Key: WPFQGYZXJAHAAW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1184.52 | Molecular Weight (Monoisotopic): 1183.4905 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Sun D, Zhang J, Dong G, He S, Sheng C.. (2022) Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein Degradation., 65 (21.0): [PMID:36306471] [10.1021/acs.jmedchem.2c01159] |
Source(1):